BeOne Medicines

BeOne Medicines BeOne Medicines is a global oncology company that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide.

BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of n

early 12,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them. To learn more about BeOne, please visit www.beonemedicines.com and follow us on LinkedIn, X, Facebook and Instagram. We all share the responsibility to report adverse events observed with our products so that they may be investigated, actioned, and communicated accordingly. To report an adverse event or side effect, please talk to your healthcare provider and contact us here: https://beonemedicines.com/contact-us/report-adverse-events/

No two blood cancer journeys are the same. Disease biology, risk factors, personal priorities, and treatment goals al...
09/02/2026

No two blood cancer journeys are the same.

Disease biology, risk factors, personal priorities, and treatment goals all shape the choices patients and physicians make throughout the care journey.

This , we’re highlighting the importance of understanding the individual behind every diagnosis and continuing to advance more personal blood cancer care.

Learn more: https://bit.ly/4xsIo3k

Investing in the next generation means creating opportunities to learn, grow and make meaningful connections. As our 202...
08/28/2026

Investing in the next generation means creating opportunities to learn, grow and make meaningful connections.

As our 2026 summer internship program comes to a close, we’re saying thank you to our interns for the fresh perspectives, curiosity and energy they brought to BeOne.

Swipe to see what made their summer meaningful and hear about their experiences.

Read more: https://beonemedicines.com/stories/beone-interns-summer-internship-experience/?utm_campaign=beone_01_pan_ub_corpaff_dtc_global_fy26_int-prog-reflections&utm_content=cs5647878&utm_medium=social&utm_source=facebook_pid000000_organic-post&utm_term=ts9077275

08/26/2026

The tournament may be over, but our commitment to patients facing cancer doesn’t stop. Every action, every decision, and every moment is focused on helping people get the care they need – One Save Changes Everything.​ Learn more: https://bit.ly/3PUMtg6

From the football pitch to cancer care, one save can change everything.Our Swiss team recently united for a summer event...
08/20/2026

From the football pitch to cancer care, one save can change everything.

Our Swiss team recently united for a summer event in Basel, joined by FC Basel 1893 goalkeepers Jonas Omlin and Renato Widmer. They reflected on performing under pressure, the importance of teamwork and what it means to stay focused when the stakes are high.

It was a great opportunity to celebrate our new partnership with FC Basel, and connect with colleagues.

Thank you to our Swiss team for their passion and drive in bringing our shared purpose to life.

08/18/2026

Cancer has no borders, neither do we.

Together with the BeOne Care Foundation, we’re renewing our partnership with The Max Foundation to continue advancing treatment availability in low- and middle-income countries.

By 2028, the program is projected to support around 1,000 patients and strengthen the support systems they need to achieve the best possible outcomes.

Learn more: https://ir.beonemedicines.com/news/beone-medicines-beone-care-foundation-and-the-max-foundation-renew-partnership-to-expand-access-to/94a37bb1-acd7-4976-91ed-bf6b84e2499e

08/14/2026

Sports teach us that achievement is earned long before the final whistle. It's built through commitment, trust, and countless people working toward the same goal.

That same mindset is at the heart of BeOne Medicines and what drives the focus to deliver
transformative cancer therapies.

Learn more: https://bit.ly/3PUMtg6

07/23/2026

Every investment in innovation brings us closer to new treatment possibilities for people living with cancer.

We're announcing a $300 million expansion of our flagship U.S. manufacturing and clinical R&D facility at the Princeton West Innovation Campus in Hopewell, New Jersey. The investment adds small molecule manufacturing capacity, brings our total U.S. manufacturing investment to more than $1 billion. It represents another important step in our ability to develop, manufacture and deliver transformative cancer medicines to more patients in the U.S. around the world, faster, more reliably and at scale.

🔗Read more: https://ir.beonemedicines.com/news/beone-medicines-expands-us-manufacturing-with-total-investment-of-more-than-dollar1-billion-to-advance/ed73c96c-c5b5-4fbe-929a-d13e2f3f4a61

Together, we're how the world stops cancer.

07/09/2026

🩸Still have questions about using AI in blood cancer care?

Join us on Wednesday July 15 at 1 PM ET / 6 PM BST for our first Educational Forum Watch Party as we revisit one of our most popular sessions: Empowered by AI: Navigating Blood Cancer Care Through Technology with Lisa Porat and Anand Reddi.

This engaging discussion explores how artificial intelligence can help patients, caregivers, healthcare providers, and advocates navigate the complexities of blood cancer care with greater confidence and empowerment.

We're especially grateful to Lisa Porat, MSW, LCSW, FAOSW, BeOne Medicines Director of North America Patient Partnerships, and Anand Reddi, BeOne Medicines Global Head of Direct-to-Customer Innovation and Digital Health, for joining us live to answer additional questions in this new watch party format.

📺 Watch the session together
💬 Stay for a live Q&A
❓ Submit questions in advance: https://ow.ly/4G4J50ZhlBI

Register today: https://ow.ly/sF3Q50ZhlBJ

07/08/2026

CLL Society latest webinar brings you clarity on Medicare Part D.

July 22 at 9am PT / 12pm ET, legal experts Saira Sultan and Kay Scanlan break down what patients need to know about Medicare Part D in 2026.

Understand your coverage options, protect your access to CLL medications, make informed decisions about your healthcare.

Sign up: https://cllsociety.org/2026/04/medicare-part-d-in-2026-what-patients-need-to-know/

07/06/2026

Every save tells a bigger story – one of perseverance, possibility, and progress.

For researchers, clinicians, patients, and caregivers, what matters isn’t just a single outcome, but the steps that make the next one possible.

One Save Can Change Everything. Learn more: https://bit.ly/3PUMtg6

Address

55 Cambridge Parkway, Suite 700W
Cambridge, MA
02142

Telephone

+18778285568

Website

,

Alerts

Be the first to know and let us send you an email when BeOne Medicines posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category